ETHYL_(3-S)-4-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-4-HYDROXY-3-METHYL-2-BUTENOATE
Compound with spectra: 1 NMR
![ETHYL_(3-S)-4-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-4-HYDROXY-3-METHYL-2-BUTENOATE](/api/compound/GxKYLcVzu9Y.png?ph=true&h=300&w=458 "ETHYL_(3-S)-4-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-4-HYDROXY-3-METHYL-2-BUTENOATE")
| SpectraBase Compound ID | GxKYLcVzu9Y |
|---|---|
| InChI | InChI=1S/C20H28NO9P/c1-4-29-17(22)12-14(2)19(24)31(26,27)11-10-16(18(23)28-3)21-20(25)30-13-15-8-6-5-7-9-15/h5-9,12,16,19,24H,4,10-11,13H2,1-3H3,(H,21,25)(H,26,27)/b14-12+/t16-,19?/m0/s1 |
| InChIKey | IQDDFEQQQYZRJY-NJLYNARTSA-N |
| Mol Weight | 457.42 g/mol |
| Molecular Formula | C20H28NO9P |
| Exact Mass | 457.150168 g/mol |
| Enantiomer InChIKey | IQDDFEQQQYZRJY-YPWABSRESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
DIMETHYL_(3-S)-2-[(((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL)-METHYL]-BUTAN-1,4-DIOATE
PHRRNLKLDAHFKN-AJWVYOOVSA-N
N-carboxy-L-3-phenylalanine, N-benzyl o-nitrophenyl ester
N-Benzyloxycarbonyl-A-benzyl-ester-D-L-A-amino-adipoyl-S-benzyl-L-cysteinyl-glycine benzyl ester
N-(4-Methoxy-benzyloxycarbonyl)-A-(4-methoxy-benzyl-ester)-D-L-A-amino-adipoyl-L-vinyl-glycine-glycine benzhydryl ester
(2S)-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-4-[2-oxo-4-(phenylmethoxycarbonylamino)-1-pyrimidinyl]butanoic acid methyl ester
METHYL-2-[N-BENZYLOXYCARBONYL]-AMINO-3,3-DIFLUORO-4-OXO-5-PHENYLPENT-4-ENOATE
N-(BENZYLOXYCARBONYL)-3-[ETHOXY-(METHOXYCARBONYLMETHYL)-PHOSPHORYL]-ALANINE-METHYLESTER
4-O-ACETYL-1,3-BIS-[N-(BENZYLOXYCARBONYL)]-2,5-DIDEOXYSTREPTAMINE
BOC-ABU(PO3ME2)-LEU-O-BZL;2-(TERT.-BUTYLOXYCARBONYLAMINO)-4-(DIMETHYLPHOSPHONO)-BUTANOYLLEUCINE-BENZYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |